Linical Co (TSE:2183) PEG Ratio: N/A (As of Jul. 05, 2026)


TSE:2183 Linical Co Ltd TSE:2183
48 GF Score
Price 円216.00
GF Value 円313.51
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Linical Co's PE Ratio without NRI is 0.00. Linical Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Linical Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Linical Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Linical Co's highest PEG Ratio was 28.16. The lowest was 0.64. And the median was 1.63.


TSE:2183's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.03
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Linical Co  (TSE:2183) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Linical Co PEG Ratio Related Terms


Linical Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for Linical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co PEG Ratio Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 25.23 0.00 0.00

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.23 2.04 0.00 0.00 0.00

TSE:2183 vs VRTX, REGN, ALNY: PEG Ratio Comparison

For the Biotechnology subindustry, Linical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Linical Co PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Linical Co's PEG Ratio falls into.


TSE:2183
48GF Score
Linical Co Ltd TSE:2183
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Linical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円216.00 is trading 31.1% below its estimated GF Value™ of 円313.51. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • PEG Ratio: N/A
  • GF Value™: 円313.51 vs. price of 円216.00 (31.1% below fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
48GF Score

Get the complete analysis for TSE:2183

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円216.00
Price
円313.51
GF Value